No Data
No Data
Scancell Signs New Commercial License Deal With Genmab
Scancell Strikes Deal Worth up to $630m With Genmab | AIM:SCLP, OTC:SCNLF
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Genmab Price Target Lowered to DKK 1,700 From DKK 2,050 at JPMorgan
European Stocks Will See Downtrend Mid-year 2025 Before Recovery
Genmab Discloses Share Transactions by Executives
No Data
No Data